118 related articles for article (PubMed ID: 3895171)
1. Bitolterol mesylate: a beta-adrenergic agent. Chemistry, pharmacokinetics, pharmacodynamics, adverse effects and clinical efficacy in asthma.
Walker SB; Kradjan WA; Bierman CW
Pharmacotherapy; 1985; 5(3):127-37. PubMed ID: 3895171
[TBL] [Abstract][Full Text] [Related]
2. New beta 2-adrenergic agonist aerosols.
Kelly HW
Clin Pharm; 1985; 4(4):393-403. PubMed ID: 2864159
[TBL] [Abstract][Full Text] [Related]
3. Dose-response study of nebulized bitolterol mesylate solution in asthmatic patients.
Pinnas JL; Bhatt BD; Campbell SC; Kemp JP; Tinkelman DG
Chest; 1987 Apr; 91(4):533-9. PubMed ID: 3549173
[TBL] [Abstract][Full Text] [Related]
4. Bitolterol and albuterol metered-dose aerosols: comparison of two long-acting beta 2-adrenergic bronchodilators for treatment of asthma.
Orgel HA; Kemp JP; Tinkelman DG; Webb DR
J Allergy Clin Immunol; 1985 Jan; 75(1 Pt 1):55-62. PubMed ID: 3968329
[TBL] [Abstract][Full Text] [Related]
5. Bitolterol mesylate in exercise-induced asthma.
Walker SB; Bierman CW; Pierson WE; Shapiro GG; Furukawa CT; Mingo TS
J Allergy Clin Immunol; 1986 Jan; 77(1 Pt 1):32-6. PubMed ID: 3944373
[TBL] [Abstract][Full Text] [Related]
6. The influences of the route of administration on the metabolism and excretion of bitolterol, a new bronchodilator, in the rat.
Aimoto T; Ito O; Kimura R; Murata T; Ito K
Xenobiotica; 1979 Mar; 9(3):173-80. PubMed ID: 473792
[TBL] [Abstract][Full Text] [Related]
7. Bitolterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible obstructive airways disease.
Friedel HA; Brogden RN
Drugs; 1988 Jan; 35(1):22-41. PubMed ID: 3278878
[TBL] [Abstract][Full Text] [Related]
8. Bitolterol mesylate (WIN 32784) aerosol. A new long-acting bronchodilator with reduced chronotropic effects.
Kass I; Mingo TS
Chest; 1980 Aug; 78(2):283-7. PubMed ID: 6995040
[TBL] [Abstract][Full Text] [Related]
9. Concomitant bitolterol mesylate aerosol and theophylline for asthma therapy, with 24 hr electrocardiographic monitoring.
Kemp JP; Chervinsky P; Orgel HA; Meltzer EO; Noyes JH; Mingo TS
J Allergy Clin Immunol; 1984 Jan; 73(1 Pt 1):32-43. PubMed ID: 6693665
[TBL] [Abstract][Full Text] [Related]
10. Studies on bitolterol, di-p-toluate ester of N-tert.-butylarterenol: a new long-acting bronchodilator with reduced cardiovascular effects.
Minatoya H
J Pharmacol Exp Ther; 1978 Sep; 206(3):515-27. PubMed ID: 702319
[TBL] [Abstract][Full Text] [Related]
11. Bitolterol--a new bronchodilator.
Med Lett Drugs Ther; 1985 May; 27(688):46-7. PubMed ID: 3889571
[No Abstract] [Full Text] [Related]
12. Bitolterol mesylate aerosol in adults with steroid-dependent asthma: a comparison with isoproterenol hydrochloride aerosol.
Nathan RA; Bodman SF; Storms WW; Mingo TS
Ann Allergy; 1986 Jun; 56(6):494-9. PubMed ID: 3717716
[TBL] [Abstract][Full Text] [Related]
13. Comparison of the bronchodilator effects of nebulized bitolterol mesylate and isoproterenol hydrochloride in steroid-dependent asthma.
Nathan RA; Bernstein IL; Bronsky EA; Bush RK; Chervinsky P; Condemi JJ; Dockhorn RJ; Pinnas JL; Repsher LH
J Allergy Clin Immunol; 1987 May; 79(5):822-9. PubMed ID: 3571773
[TBL] [Abstract][Full Text] [Related]
14. Outpatient management of asthma with regular nebulized beta agonists: comparison of bitolterol mesylate and isoproterenol.
Kemp JP; Orgel HA; Grossman J; Reed CE; Tinkelman DG; Webb DR; Ziment I
Ann Allergy; 1987 Jul; 59(1):17-20. PubMed ID: 3300436
[TBL] [Abstract][Full Text] [Related]
15. Pirbuterol. A preliminary review of its pharmacological properties and therapeutic efficacy in reversible bronchospastic disease.
Richards DM; Brogden RN
Drugs; 1985 Jul; 30(1):6-21. PubMed ID: 2863125
[TBL] [Abstract][Full Text] [Related]
16. Retrospective study of bitolterol mesylate in the treatment of conditions associated with reversible bronchospasm.
Messina MS
Adv Ther; 1995; 12(3):157-63. PubMed ID: 10155050
[TBL] [Abstract][Full Text] [Related]
17. Comparison of bronchodilator responses with bitolterol mesylate solution with the use of two different nebulizer systems in asthma.
Kemp JP; Pinnas JL; Tinkelman DG; Meltzer EO; Campbell SC; Orgel HA; Welch MJ; Mingo TS
J Allergy Clin Immunol; 1986 Mar; 77(3):509-15. PubMed ID: 3950254
[TBL] [Abstract][Full Text] [Related]
18. [Evaluation of procaterol aerosol as an aerosolized beta 2-adrenergic bronchodilator in conscious guinea pigs].
Arai Y; Nitta K; Shida T
Arerugi; 1985 Nov; 34(11):999-1005. PubMed ID: 2867754
[No Abstract] [Full Text] [Related]
19. Long acting beta-agonists versus theophylline for maintenance treatment of asthma.
Shah L; Wilson AJ; Gibson PG; Coughlan J
Cochrane Database Syst Rev; 2003; (3):CD001281. PubMed ID: 12917905
[TBL] [Abstract][Full Text] [Related]
20. [Bitolterol: a new bronchodilator in pediatrics].
Calvo M; Arellano EM; Marín F
Rev Chil Pediatr; 1988; 59(4):253-7. PubMed ID: 3075064
[No Abstract] [Full Text] [Related]
[Next] [New Search]
